Laurence Postelmans

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Sub-inner limiting membrane haemorrhage: causes and treatment with vitrectomy

K. De Maeyer, Rita Van Ginderdeuren, Laurence Postelmans et al. · British Journal of Ophthalmology · 2007 · 108 citations · Full text

Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females

Laurence Postelmans, Brigitte Pasteels, Pascale Coquelet et al. · American Journal of Ophthalmology · 2004 · 85 citations

Ocular Disease, Ophthalmology, Photodynamic Therapy +8

Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis

B Snyers, Claire Verougstraete, Laurence Postelmans et al. · American Journal of Ophthalmology · 2004 · 40 citations

Type 2A, Ocular Disease, Retina +6

Photodynamic Therapy for Subfoveal Classic Choroidal Neovascularization Related to Punctate Inner Choroidopathy (PIC) or Presumed Ocular Histoplasmosis-Like Syndrome (POHS-Like)

Laurence Postelmans, Brigitte Pasteels, Pascale Coquelet et al. · Ocular Immunology and Inflammation · 2005 · 35 citations